Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
AI Detects Retinopathy of Prematurity with 100% Accuracy
In a study published in JAMA Ophthalmology, researchers from Oregon Health & Science University (OHSU) alongside international collaborators have unveiled an artificial intelligence (AI) technology capable of independently detecting all severe cases of a condition leading to blindness in prematurely…
Can I Use Eye Drops While Fasting?
In the period of Ramadan, a time when millions around the globe engage in fasting from sunrise to sunset, questions often arise about how certain health practices, such as the use of eye drops, fit within the fasting rules. With…
MediPrint Finalizes Glaucoma Contact Lens Study
MediPrint Ophthalmics has successfully completed its SIGHT-2 phase 2b study, showcasing the efficacy of its innovative product, LL-BMT1, against a control group using bimatoprost 0.01% ophthalmic solution. LL-BMT1, a preservative-free, weekly drug-eluting contact lens, utilizes the company’s 3D printing technology,…
Novel Gene Editing Breakthrough for Eye Conditions
Researchers at the Broad Institute of MIT and Harvard have made a breakthrough in gene editing technology, introducing a new method for delivering prime editing tools into cells of living animals. This advancement, detailed in a study published in Nature…
Vital Tears Names Joseph Tauber, MD as CMO
Vital Tears, known for its innovative autologous serum tears, is excited to announce the appointment of Joseph Tauber, MD, to the role of Chief Medical Officer (CMO). This strategic addition aims to fortify the company’s commitment to leading-edge research, physician…
The Link Between Cortical Blindness and Schizophrenia
Blindness and schizophrenia are two distinct conditions that, at first glance, may seem unrelated. However, emerging research indicates a fascinating and complex relationship between the two, suggesting that congenital or early-life blindness may significantly reduce the risk of developing schizophrenia.…
Study Finds Neurolens Lenses Reduce Headache
Neurolens announced the findings of a research study aimed at evaluating the efficacy of its prescription lenses for individuals suffering from headaches. Conducted across 10 optometry practices involving 195 patients, this company-sponsored study utilized the six-item Headache Impact Test (HIT-6)…
Sandoz Finalizes Acquisition of Cimerli from Coherus
Sandoz has successfully completed the acquisition of the United States biosimilar, Cimerli (ranibizumab-eqrn), from Coherus BioSciences. This strategic move underscores Sandoz’s commitment to expanding its portfolio in the biopharmaceutical sector, particularly in the area of biosimilars. The transaction, initially announced…
The Optical Company Acquires Adelaide Eye Care
In a landmark move that expands its network to 60 locations, The Optical Company (TOC) has officially acquired all three Adelaide Eye Care (AEC) optometry practices. This expansion is the first major acquisition for TOC in 2024, adding to a…
Amring Pharma Announces Name Change to Nordic Pharma
In a significant corporate rebranding, Amring Pharmaceuticals has officially adopted the name Nordic Pharma. This renaming marks a new chapter following the acquisition by Nordic Group, a subsidiary of Sever Life Sciences, on June 1, 2023. The strategic move aims…